Instruments

Name Stock exchange Average volume Price Type
GLOBAL CORD BLOOD CORPORATION CORBF

OTC Markets +2 Other

6,034 1.25 USD Stock Global Cord Blood Corporation Stock
GLOBAL CORD BLOOD CORPORATION 6CB

Deutsche Boerse AG

- 3.84 EUR Stock Global Cord Blood Corporation
GLOBAL CORD BLOOD CORPORATION 6CB

Börse Stuttgart

- 3.96 EUR Stock Global Cord Blood Corporation

News (260)

CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease GL
DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system. EQ
Evotec : Remuneration report 2023 on agenda item 5, PU
Evotec : Convening and Agenda of the Annual General Meeting, PU
Evotec : Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212, PU
Bayer and Evotec collaborate to advance precision cardiology EQ
Transcript : Evotec SE, 2023 Earnings Call, Apr 24, 2024
Evotec : Corporate governance declaration for the 2023 financial year, PU
Evotec : Declaration on Corporate Governance 2023 581.471 KB PU
DD: Evotec SE: Dr. Cord Dohrmann, sell EQ
Transcript : Evotec SE - Special Call
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan) EQ
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan) EQ
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan) EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan) EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan) EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan) EQ
Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb EQ
Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes EQ
Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases EQ
Evotec SE, Video recording of Capital Markets Day presentations published AQ
Transcript : Evotec SE - Analyst/Investor Day
Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day EQ
Transcript : Evotec SE, Nine Months 2023 Earnings Call, Nov 08, 2023
Transcript : Evotec SE, H1 2023 Earnings Call, Aug 29, 2023
Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership EQ
Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme EQ
Evotec-Sernova Partnership, Successful Results Presented at the 4th IPITA/HSCI/JDRF Summit AQ
Successful Results Using Sernova's Cell Pouch System with Evotec's iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit AQ
Successful Results Using Sernova’s Cell Pouch System™ with Evotec’s iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit AQ
Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership EQ
Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb EQ
Evotec : partner Sernova to present at the 4th IPITA / HSCI / JDRF Summit PU
Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit EQ
Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit AQ
Evotec : announces agreement with Janssen to develop immune-based therapies PU
Evotec announces agreement with Janssen to develop immune-based therapies EQ
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan) EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against cash settlement (Share Performance Plan) EQ
Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes EQ
Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes AQ
Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb AQ
Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb EQ
Transcript : Evotec SE, Nine Months 2022 Earnings Call, Nov 09, 2022
Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases AQ
1234NextSee all

Companies (142)

SRF LIMITED 7 908 M $
Logo SRF Limited

SRF Limited is a chemical-based multi-business company engaged in the manufacturing of industrial and specialty intermediates. The Company's segments include Technical Textiles Business (TTB), Chemicals Business (CB), Packaging Film Business (PFB) and Oth ...

GLOBAL CORD BLOOD CORPORATION 167 M $
Logo Global Cord Blood Corporation

Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It pro ...

CRYO-CELL INTERNATIONAL, INC. 72 M $
Logo Cryo-Cell International, Inc.

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem c ...

STEMCELL INSTITUTE INC. 126 M $
Logo StemCell Institute Inc.

StemCell Institute Inc is mainly engaged in the cell bank business, which separates and stores cord blood. The Company operates cell bank business from umbilical cord blood and umbilical cord, development of new treatment methods and regenerative medicine ...

PT INDO KORDSA TBK 161 M $
Logo PT Indo Kordsa Tbk

PT Indo Kordsa Tbk is an Indonesia-based company, which is engaged in manufacturing and marketing of tire cord fabric, yarn filaments (nylon fiber, polyester fiber, rayon fiber), nylon tire cord, and raw materials of polyester (purified terephthalic acid) ...

MEDIPOST CO., LTD. 171 M $
Logo MEDIPOST Co., Ltd.

MEDIPOST Co., Ltd. is a Korea-based company engaged in the biotechnology business. The Company mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoieti ...

CORDLIFE GROUP LIMITED 24 M $
Logo Cordlife Group Limited

Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Company’s segments include Banking and Diagnostics ...

SHOUGANG CENTURY HOLDINGS LIMITED 65 M $
Logo Shougang Century Holdings Limited

Shougang Century Holdings Ltd is an investment holding company principally engaged in the steel cord business. The Company is engaged in the manufacture and sale of steel cords for radial tyres. Steel cords are also used for truck tyres, off the road truc ...

ZHEJIANG UNIFULL INDUSTRIAL FIBRE CO., LTD. 459 M $
Logo Zhejiang Unifull Industrial Fibre Co., Ltd.

ZHEJIANG UNIFULL INDUSTRIAL FIBRE CO.,LTD is a China-based company principally engaged in the research and development, manufacture and distribution of polyester filaments and lithium batteries. The polyester filament products of the Company include polye ...

SUCCESS PRIME CORPORATION 44 M $
Logo Success Prime Corporation

SUCCESS PRIME CORPORATION is a Taiwan-based company principally engaged in the development, manufacture and sale of optical fibers. The Company operates in two business segments. The Fiber Optics segment’s primary products include single-mode optical fi ...


1234Next

Insiders

Picture Cord Dohrmann
Cord Dohrmann

Presently, Cord E. Dohrmann holds the position of Chief Scientific Officer at Evotec SE and Co-Managing Director at Evotec International GmbH (a subsidiary of Evotec SE). He is also on the board of Eternygen GmbH and FSHD Unlimited Cooperatie Ua. He previously was Chief Executive Officer of DeveloGen AG, Principal at The General Hospital Corp., Principal at Eberhard Karls Universität Tübingen and Principal at Duke University. Dr. Dohrmann received a graduate degree from Max-Planck-Institute for Molecular Genetics, an undergraduate degree from Eberhard Karls Universität Tübingen and a doctorate from Harvard Medical School.










Picture David Dohrmann
David Dohrmann

David Lisle Dohrmann was the founder and had founded Playchemy, Inc. in 2010, where he served as the Chief Executive Officer from 2010 to 2012.
He is currently the President, Chief Executive Officer, CFO & Director at GrowLife, Inc. since 2021.
Previously, he was the Chief Executive Officer & Secretary at Gazillion, Inc. from 2015 to 2018.
He also held the position of Director at Private Media Group, Inc. Additionally, he worked as the Managing Director at ROTH Capital Partners LLC from 2013 to 2016.
Prior to that, he was the Vice President-Corporate Development at Sagent Technology, Inc. from 2000 to 2002.
He also served as a Partner at Security Research Associates, Inc. and Principal at Donaldson, Lufkin & Jenrette Securities Corp.
Furthermore, he was a Partner at Halpern Capital, Inc. from 2002 to 2005.
Mr. Dohrmann obtained his undergraduate degree from the University of Southern California in 1989.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW